Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,889.00
-3.50(-0.06%)
Dow Futures
43,051.00
-118.00(-0.27%)
Nasdaq Futures
20,523.50
-18.50(-0.09%)
Russell 2000 Futures
2,244.60
-1.60(-0.07%)
Crude Oil
72.24
+0.15(+0.21%)
Gold
2,753.40
-6.40(-0.23%)

Cipher Pharmaceuticals Inc. (CPH.TO)

Toronto - Toronto Real Time Price. Currency in CAD

Follow

16.43

-0.07

(-0.42%)

At close: 03:59PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	422.21M
Enterprise Value	356.40M
Trailing P/E	13.27
Forward P/E	11.17
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	13.40
Price/Book (mrq)	3.44
Enterprise Value/Revenue	11.65
Enterprise Value/EBITDA	21.72

Trading Information

Stock Price History

Beta (5Y Monthly)	1.20
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	19.69
52 Week Low ³	4.30
50-Day Moving Average ³	16.11
200-Day Moving Average ³	10.15

Share Statistics

Avg Vol (3 month) ³	82.7k
Avg Vol (10 day) ³	45.73k
Shares Outstanding ⁵	25.59M
Implied Shares Outstanding ⁶	N/A
Float ⁸	14.49M
% Held by Insiders ¹	42.00%
% Held by Institutions ¹	1.38%
Shares Short (Oct 15, 2024) ⁴	87.99k
Short Ratio (Oct 15, 2024) ⁴	1.08
Short % of Float (Oct 15, 2024) ⁴	N/A
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.34%
Shares Short (prior month Sep 13, 2024) ⁴	73.47k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	102.01%
Operating Margin (ttm)	48.81%

Management Effectiveness

Return on Assets (ttm)	7.90%
Return on Equity (ttm)	28.43%

Income Statement

Revenue (ttm)	22.16M
Revenue Per Share (ttm)	0.91
Quarterly Revenue Growth (yoy)	0.30%
Gross Profit (ttm)	N/A
EBITDA	12.07M
Net Income Avi to Common (ttm)	22.6M
Diluted EPS (ttm)	1.24
Quarterly Earnings Growth (yoy)	-2.50%

Balance Sheet

Total Cash (mrq)	47.98M
Total Cash Per Share (mrq)	1.88
Total Debt (mrq)	296k
Total Debt/Equity (mrq)	0.33
Current Ratio (mrq)	11.18
Book Value Per Share (mrq)	3.68

Cash Flow Statement

Operating Cash Flow (ttm)	17.05M
Levered Free Cash Flow (ttm)	5.53M